Anti-SPINK4 Antilichaam PE Vervoeging

Predicted to enable serine-type endopeptidase inhibitor activity. Predicted to be located in extracellular region.

SPINK4; Serine protease inhibitor Kazal-type 4; Peptide PEC-60 homolog

SPINK4

27290

O60575

Human

No cross-reactivity with other proteins

A synthetic peptide corresponding to a sequence at the N-terminus of human SPINK4.

Flow Cytometry

Immunogen affinity purified.

Liquid

1. Hartz, P. A. Personal Communication. Baltimore, Md. 4/20/2011. 2. Metsis, M., Cintra, A., Solfrini, V., Ernfors, P., Bortolotti, F., Morrasutti, D. G., Ostenson, C.-G., Efendic, S., Agerberth, B., Mutt, V., Persson, H., Fuxe, K. Molecular cloning of PEC-60 and expression of its mRNA and peptide in the gastrointestinal tract and immune system. J. Biol. Chem. 267: 19829-19832, 1992. 3. Norberg, A., Gruber, S., Angelucci, F., Renlund, S., Wadensten, H., Efendic, S., Ostenson, C.-G., Jornvall, H., Sillard, R., Mathe, A. A. Identification of the bioactive peptide PEC-60 in brain. Cell. Molec. Life Sci. 60: 378-381, 2003.

At -20 ̊C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.

6

Serine peptidase inhibitor Kazal type 4

Serine protease inhibitor Kazal-type 4

Rabbit IgG

Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4, 0.02% NaN3.